{"id":2222,"date":"2019-07-05T18:27:30","date_gmt":"2019-07-05T18:27:30","guid":{"rendered":"http:\/\/blog.valuengine.com\/?p=2222"},"modified":"2019-07-15T15:09:40","modified_gmt":"2019-07-15T15:09:40","slug":"valuengine-weekly-market-update-7-5-2019","status":"publish","type":"post","link":"http:\/\/blog.valuengine.com\/index.php\/valuengine-weekly-market-update-7-5-2019\/","title":{"rendered":"ValuEngine Weekly Market Update, 7\/5\/2019"},"content":{"rendered":"\n<p>ValuEngine Market Valuation update for the week of July 5, 2019. Stock pick of the week is ticker SRPT (Sarepta Therapeutics Inc). There have been some changes in overall Sector group valuations, read on for updated numbers.<\/p>\n\n\n\n<p><a rel=\"noreferrer noopener\" href=\"http:\/\/www.valuengine.com\/ve\/mainve?pid=1\" target=\"_blank\">www.ValuEngine.com<\/a>&nbsp;to log in, or free two-week full trial. Over 5,000 stocks, 16 sector groups, 140 plus industries covered every day.<\/p>\n\n\n<a href=\"http:\/\/blog.valuengine.com\/wp-content\/uploads\/2019\/07\/190705-VE-WeeklyReport.pdf\" class=\"pdfemb-viewer\" style=\"\" data-width=\"max\" data-height=\"max\" data-mobile-width=\"500\"  data-scrollbar=\"none\" data-download=\"on\" data-tracking=\"on\" data-newwindow=\"on\" data-pagetextbox=\"off\" data-scrolltotop=\"off\" data-startzoom=\"100\" data-startfpzoom=\"100\" data-toolbar=\"bottom\" data-toolbar-fixed=\"off\">190705-VE-WeeklyReport<br\/><\/a>\n<p class=\"wp-block-pdfemb-pdf-embedder-viewer\"><\/p>\n\n\n\n<p>Subscribers log in&nbsp;<a href=\"http:\/\/www.valuengine.com\/ve\/mainve?pid=1\" target=\"_blank\" rel=\"noreferrer noopener\">HERE<\/a><\/p>\n\n\n\n<p>Free Two Week Trial to all 5,000 plus equities covered by ValuEngine&nbsp;<a href=\"http:\/\/www.valuengine.com\/pub\/VeSubscribeInfo?pid=1\" target=\"_blank\" rel=\"noreferrer noopener\">HERE<\/a><\/p>\n\n\n\n<p>Paul Henneman | President\/CEO | support@ValuEngine.com | ValuEngine, Inc<\/p>\n","protected":false},"excerpt":{"rendered":"<p>ValuEngine Market Valuation update for the week of July 5, 2019. Stock pick of the week is ticker SRPT (Sarepta Therapeutics Inc). There have been some changes in overall Sector group valuations, read on for updated numbers. www.ValuEngine.com&nbsp;to log in, or free two-week full trial. Over 5,000 stocks, 16 sector groups, 140 plus industries covered &#8230; <a title=\"ValuEngine Weekly Market Update, 7\/5\/2019\" class=\"read-more\" href=\"http:\/\/blog.valuengine.com\/index.php\/valuengine-weekly-market-update-7-5-2019\/\" aria-label=\"More on ValuEngine Weekly Market Update, 7\/5\/2019\">Read more<\/a><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[1,39],"tags":[1521,1479,1471,1524,1523,1478,1525,1463,1467,1522,1462,1066,947,28],"_links":{"self":[{"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/posts\/2222"}],"collection":[{"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/comments?post=2222"}],"version-history":[{"count":2,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/posts\/2222\/revisions"}],"predecessor-version":[{"id":2228,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/posts\/2222\/revisions\/2228"}],"wp:attachment":[{"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/media?parent=2222"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/categories?post=2222"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/tags?post=2222"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}